Finance

Lists
Q2 2027 earnings • in 5 days
See details
7733:TYO
Olympus Corp
Â¥1,845.50
+6.68%
(+115.50) 1D
Nov 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 7733...
Open
Â¥1,810
High
Â¥1,852
Low
Â¥1,790
Mkt. cap
2.06T
Avg. vol.
5.18M
Volume
8.00M
Dividend
1.63%
Quarterly dividend
Â¥8
Ex-dividend date
Mar 28, 2024
P/E ratio
25.92
52-wk high
Â¥2,210
52-wk low
Â¥1,302
EPS
Â¥71
Shares outstanding
341.42M
No. of employees
28K
Open
Â¥1,810
High
Â¥1,852
Low
Â¥1,790
Mkt. cap
2.06T
Avg. vol.
5.18M
Volume
8.00M
Dividend
1.63%
Quarterly dividend
Â¥8
Ex-dividend date
Mar 28, 2024
P/E ratio
25.92
52-wk high
Â¥2,210
52-wk low
Â¥1,302
EPS
Â¥71
Shares outstanding
341.42M
No. of employees
28K
News stories
From web sources and news partners
Profile
Olympus Corporation is a Japanese manufacturer of optics and reprography products, headquartered in Hachioji, Tokyo. Olympus was founded on October 12, 1919 as Takachiho Seisakusho by Takeshi Yamashita, initially specializing in microscopes and thermometers, and later in imaging. In 1921, the name Olympus was registered as a trademark. In 1942, the company was renamed Takachiho Optical Industries, and in 1949 it was renamed Olympus Optical Co., Ltd. In 2003, the company adopted its current name, Olympus Corporation. Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. As of 2025, endoscopes and related surgical technologies are now Olympus's exclusive product line. It was formerly also a maker of cameras, camera lenses and dictaphones, until it divested this part to OM Digital Solutions in 2020. It divested from its microscopy and scientific imaging division in 2023, selling it to Bain Capital for approximately $3.1 billion; the division operates as Evident Corporation. Wikipedia
About Olympus Corp
CEOYasuo Takeuchi
Employees28.1K
FoundedOct 12, 1919
Headquarters-
SectorMedical device
Industry-
Websiteolympus.co.jp
Next call in 5 days
Tue, Nov 10, 8:00 AM
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
- / 267.53B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
247.84B
261.04B
295.28B
240.40B
Cost of goods sold
86.54B
96.15B
102.52B
83.57B
Cost of revenue
86.54B
96.15B
102.52B
83.57B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
119.90B
125.65B
104.14B
125.03B
Operating expense
127.74B
140.86B
133.39B
126.76B
Total operating expenses
214.27B
237.01B
235.91B
210.33B
Operating income
33.56B
24.04B
59.37B
30.07B
Other non operating income
-
-
-866.00M
-
EBT including unusual items
27.90B
22.13B
27.08B
27.56B
EBT excluding unusual items
27.90B
22.13B
59.58B
27.56B
Income tax expense
7.70B
7.96B
2.26B
8.46B
Effective tax rate
27.61%
35.98%
8.36%
30.69%
Other operating expenses
7.83B
15.21B
-5.95B
1.72B
Net income
20.20B
14.17B
24.82B
19.10B
Net profit margin
8.15%
5.43%
8.40%
7.95%
Earnings per share
-
-
-
-
Interest and investment income
3.64B
356.00M
3.96B
1.43B
Interest expense
-5.28B
-2.34B
-2.88B
-2.82B
Net interest expenses
-1.64B
-1.99B
1.09B
-1.39B
Depreciation and amortization charges
-
-
35.20B
-
EBITDA
50.30B
41.76B
75.92B
47.38B
Gain or loss from assets sale
-
-
12.08B
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps